According to a 2021 Gallup poll, an estimated 18 million Americans can’t afford to pay for their much-needed prescription drugs. Across the nation people are having to choose between paying debilitating costs for prescriptions, or going without. It is no different here in Nevada. In fact, prescription drug prices in our state are climbing. Name brand drugs that treat cancer, asthma or diabetes increased as much as 73% between 2015 and 2020. So why is this happening? These skyrocketing prices are due, in part, to questionable business practices of Pharmacy Benefit Managers. So what is being, or can be, done about PBMs?